Enhancing triapine treatment: strategies for dose optimization and methemoglobin level mitigation.

Saved in:
Bibliographic Details
Title: Enhancing triapine treatment: strategies for dose optimization and methemoglobin level mitigation.
Authors: Lee H; Center for Translational Medicine, University of Maryland School of Pharmacy, 20 North Pine Street, Baltimore, MD, 21201, USA., Dunn A; Center for Translational Medicine, University of Maryland School of Pharmacy, 20 North Pine Street, Baltimore, MD, 21201, USA., Taylor SE; Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA., Chauhan A; Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA., Ivy SP; Investigational Drug Branch, Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA., Gobburu J; Center for Translational Medicine, University of Maryland School of Pharmacy, 20 North Pine Street, Baltimore, MD, 21201, USA., Beumer JH; Cancer Therapeutics Program, UPMC Hillman Cancer Centre, Pittsburgh, PA, USA. jan.beumer@jhu.edu.; Department of Oncology, Johns Hopkins University School of Medicine and Johns Hopkins Sidney Kimmel Cancer Center, 1650 Orleans St, Room 1M52, Baltimore, MD, 21287, USA. jan.beumer@jhu.edu.
Source: Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2026 May 20; Vol. 96 (1). Date of Electronic Publication: 2026 May 20.
Publication Type: Journal Article; Clinical Trial, Phase I
Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0843 (Electronic) Linking ISSN: 03445704 NLM ISO Abbreviation: Cancer Chemother Pharmacol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1432-0843
DOI:10.1007/s00280-026-04898-6